Vision Sciences Aktie
WKN DE: A14NUS / ISIN: US19243A1043
02.04.2025 13:53:28
|
Cognyte Software Q4 Net Loss Narrows, Sees Profit, Revenue Growth In FY26; Stock Up - Update
(RTTNews) - Cognyte Software Ltd. (CGNT), while reporting narrower net loss and higher revenues in its fourth quarter, on Wednesday issued fiscal 2026 outlook, expecting increased profit and revenues.
In pre-market activity on the Nasdaq, Cognyte Software shares were gaining around 3.7 percent to trade at $8.52.
For fiscal 2026, the Investigative analytics software provider projects adjusted earnings per share of $0.16, and adjusted EBITDA of approximately $43 million.
Revenue is expected to be $392 million at the midpoint with a range of +/-2%, representing around 12% growth from previous year revenue.
In fiscal 2025, adjusted earnings were 0.06 per share and adjusted EBITDA was $29.11 million with revenue of $350.63 million.
David Abadi, Cognyte's chief financial officer, said, "For fiscal 2026, we expect another year of double-digit revenue growth with profitability growing significantly faster than the top line."
In its fourth quarter, net loss was $1.23 million, narrower than loss of $2.61 million in the same period last year. Loss per share was $0.02, compared to loss of $0.04 per share a year ago.
Adjusted earnings were $1.98 million or $0.03 per share for the period.
Revenue grew to $94.51 million from $83.69 million in the same period last year.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Vision Sciences Inc (Del.)mehr Nachrichten
Keine Nachrichten verfügbar. |